ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AKBA Akebia Therapeutics Inc

1.12
-0.03 (-2.61%)
22 May 2024 - Closed
Delayed by 15 minutes

Akebia Therapeutics Financial Summary

The current AKBA market cap is 234.5M. The company's latest EPS is USD -0.2480 and P/E is -4.56.

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 55.18M40.13M56.25M42.05M56.2M
Operating Income -6.35M-24.94M-9.66M-13.04M1.37M
Net Income -7.55M-26.22M-11.83M-14.49M614k
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 335M295.31M213.58M292.6M194.62M
Operating Income -286.29M-376.44M-265.32M-79.12M-46.26M
Net Income -279.66M-383.46M-282.84M-92.56M-51.93M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 351.83M276.86M253.71M235M241.7M
Total Liabilities 342.49M291.21M280.52M274.42M272.29M
Total Equity 9.34M-14.35M-26.81M-39.42M-30.58M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 771.2M644.14M525.55M351.83M241.7M
Total Liabilities 376.44M396.52M449.09M342.49M272.29M
Total Equity 394.76M247.62M76.46M9.34M-30.58M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -73.15M-17.54M-13.91M-21.08M-23.38M
Investing -114k N/A N/A N/A N/A
Financing 14.6M-15.97M-23.97M-23.92M-25.21M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -257.44M-110.39M-252.97M-73.15M-23.38M
Investing 211.18M-40M39.94M-114k N/A
Financing 88.97M231.72M133.73M14.6M-25.21M
Market Cap 234.5M
Price to Earnings Ratio -4.56
Price to Sales Ratio 1.22
Price to Cash Ratio 5.51
Price to Book Ratio -7.74
Dividend Yield -

Share Statistics

Shares Outstanding 209.37M
Average Volume (1 week) 2.81M
Average Volume (1 Month) 3.01M
52 Week Change -11.11%
52 Week High 2.48
52 Week Low 0.7801
Spread (Intraday) 0.01 (0.89%)

Company Info

Company Name Akebia Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.akebia.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock